MeSH term
Frequency | Condition_Probility | Acute Disease | 2 | 0.0 |
Adult | 18 | 0.0 |
Comparative Study | 11 | 0.0 |
Humans | 83 | 0.0 |
Aged | 9 | 0.0 |
Female | 25 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 17 | 0.0 |
Receptors, Chemokine/*analysis | 2 | 5.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 32 | 0.0 |
Cells, Cultured | 20 | 0.0 |
Chemokines, CXC/*biosynthesis | 2 | 13.0 |
Chemotaxis, Leukocyte | 6 | 3.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Receptors, Chemokine/genetics | 2 | 4.0 |
Animals | 27 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Inflammation/immunology | 2 | 1.0 |
*Intercellular Signaling Peptides and Proteins | 7 | 1.0 |
Interferon Type II/pharmacology | 5 | 0.0 |
Mice | 22 | 0.0 |
Mice, Inbred BALB C | 7 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Chemokines/biosynthesis | 2 | 5.0 |
Cytokines/biosynthesis | 2 | 0.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Receptors, CXCR4/biosynthesis | 2 | 6.0 |
Receptors, Chemokine/biosynthesis | 3 | 6.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Mice, SCID | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Culture Media, Conditioned/pharmacology | 3 | 1.0 |
Interferon Type II/*pharmacology | 4 | 0.0 |
Kinetics | 5 | 0.0 |
Receptors, Chemokine/*metabolism | 7 | 4.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Chemokines, CXC/*genetics | 3 | 9.0 |
Species Specificity | 2 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
CHO Cells | 2 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Chemotaxis | 5 | 2.0 |
Hamsters | 4 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Receptors, Chemokine/genetics/*metabolism | 5 | 10.0 |
Transfection | 7 | 0.0 |
Chemokines, CXC/genetics/*metabolism | 5 | 31.0 |
Dermatitis/*immunology | 2 | 40.0 |
Gene Expression | 3 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
In Situ Hybridization | 5 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Chemotaxis, Leukocyte/*immunology | 2 | 4.0 |
Cell Line | 9 | 0.0 |
Ligands | 11 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Chemokines, CXC/*biosynthesis/genetics | 5 | 33.0 |
Protein Binding | 5 | 0.0 |
Receptors, Chemokine/metabolism | 5 | 4.0 |
Time Factors | 3 | 0.0 |
Cell Movement/drug effects | 2 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Base Sequence | 5 | 0.0 |
Chemokines, CXC/*blood | 2 | 28.0 |
CD4-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Chemokines, CC/genetics/*metabolism | 2 | 14.0 |
Chemokines, CC/metabolism | 3 | 6.0 |
Chemokines, CXC/metabolism | 2 | 2.0 |
Fetus | 2 | 0.0 |
Microglia/cytology/immunology/*virology | 2 | 100.0 |
Transforming Growth Factor beta/pharmacology | 2 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 4 | 0.0 |
Adolescent | 2 | 0.0 |
Biopsy | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Transplantation, Homologous | 2 | 0.0 |
Chemokines, CXC/*physiology | 2 | 5.0 |
Binding, Competitive | 2 | 0.0 |
Cell Line, Tumor | 7 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Chemokines, CXC/*metabolism | 3 | 5.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
Chemokines, CXC/biosynthesis | 3 | 12.0 |
Intercellular Signaling Peptides and Proteins/biosynthesis | 2 | 8.0 |
Lung/pathology | 2 | 2.0 |
Binding Sites | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Mutation | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Drug Synergism | 3 | 0.0 |
Macrophages/immunology/metabolism | 2 | 4.0 |
Up-Regulation/immunology | 3 | 1.0 |
Up-Regulation | 2 | 0.0 |
Receptors, Chemokine/genetics/metabolism | 2 | 8.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Chemotaxis/physiology | 2 | 6.0 |
In Vitro | 4 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
Th1 Cells/*immunology | 2 | 1.0 |
Chemokines/*immunology | 2 | 10.0 |
Rats | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Intercellular Signaling Peptides and Proteins/*metabolism | 2 | 2.0 |
Culture Techniques | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Receptors, Chemokine/immunology | 2 | 6.0 |
Statistics, Nonparametric | 2 | 0.0 |
